Synapse

← Multiple Sclerosis International

Papers in Multiple Sclerosis International

Page 3 · newest first

  1. Is There Extra Cost of Institutional Care for MS Patients?Multiple Sclerosis International · 2013
  2. Fatigue and Sleep-Disordered Breathing in Multiple Sclerosis: A Clinically Relevant Association?Multiple Sclerosis International · 2013
  3. Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple SclerosisMultiple Sclerosis International · 2013
  4. The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A ReviewMultiple Sclerosis International · 2013
  5. Increased Female MS Incidence and Differences in Gender-Specific Risk in Medium- and High-Risk Regions in Finland from 1981–2010Multiple Sclerosis International · 2013
  6. Biomarkers in Multiple Sclerosis: An Up-to-Date OverviewMultiple Sclerosis International · 2013
  7. Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex MeasuresMultiple Sclerosis International · 2013
  8. Factors for Lower Walking Speed in Persons with Multiple SclerosisMultiple Sclerosis International · 2013
  9. Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple SclerosisMultiple Sclerosis International · 2013
  10. Effects of Walking Direction and Cognitive Challenges on Gait in Persons with Multiple SclerosisMultiple Sclerosis International · 2013
  11. Gait Variability and Multiple SclerosisMultiple Sclerosis International · 2013
  12. The Contribution of Resting State Networks to the Study of Cortical Reorganization in MSMultiple Sclerosis International · 2013
  13. Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis OpticaMultiple Sclerosis International · 2013
  14. DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical ImplicationsMultiple Sclerosis International · 2013
  15. Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple SclerosisMultiple Sclerosis International · 2013
  16. Infodemiology and Infoveillance of Multiple Sclerosis in ItalyMultiple Sclerosis International · 2013
  17. The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple SclerosisMultiple Sclerosis International · 2013
  18. Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in SeraMultiple Sclerosis International · 2013
  19. Morphostructural MRI Abnormalities Related to Neuropsychiatric Disorders Associated to Multiple SclerosisMultiple Sclerosis International · 2013
  20. Olfactory Dysfunction in Patients with Neuromyelitis OpticaMultiple Sclerosis International · 2013
  21. The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion DevelopmentMultiple Sclerosis International · 2013
  22. Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot StudyMultiple Sclerosis International · 2013
  23. The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic ReviewMultiple Sclerosis International · 2013
  24. Brain Abnormalities in Neuromyelitis Optica Spectrum DisorderMultiple Sclerosis International · 2012
  25. Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis PathologyMultiple Sclerosis International · 2012
  26. Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence TomographyMultiple Sclerosis International · 2012
  27. Activities-Specific Balance Confidence in People with Multiple SclerosisMultiple Sclerosis International · 2012
  28. Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary StudyMultiple Sclerosis International · 2012
  29. Treadmill Training in Multiple Sclerosis: Can Body Weight Support or Robot Assistance Provide Added Value? A Systematic ReviewMultiple Sclerosis International · 2012
  30. Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled TrialMultiple Sclerosis International · 2012
  31. Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?Multiple Sclerosis International · 2012
  32. Plasma Exchange in Severe Attacks of Neuromyelitis OpticaMultiple Sclerosis International · 2012
  33. Falls and Physical Activity in Persons with Multiple SclerosisMultiple Sclerosis International · 2012
  34. Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety StudyMultiple Sclerosis International · 2012
  35. A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon TreatmentMultiple Sclerosis International · 2012
  36. Keeping Cool: Use of Air Conditioning by Australians with Multiple SclerosisMultiple Sclerosis International · 2012
  37. Benefits of Whole-Body Vibration with an Oscillating Platform for People with Multiple Sclerosis: A Systematic ReviewMultiple Sclerosis International · 2012
  38. Overall Memory Impairment Identification with Mathematical Modeling of the CVLT-II Learning Curve in Multiple SclerosisMultiple Sclerosis International · 2012
  39. The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic NeuropathiesMultiple Sclerosis International · 2012
  40. The Impact of Comorbid Depression on Adherence to Therapy for Multiple SclerosisMultiple Sclerosis International · 2011
  41. Iron and Neurodegeneration in Multiple SclerosisMultiple Sclerosis International · 2011
  42. When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?Multiple Sclerosis International · 2011
  43. Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple SclerosisMultiple Sclerosis International · 2011
  44. Serum Metabolic Profile in Multiple Sclerosis PatientsMultiple Sclerosis International · 2011
  45. Validation of the Danish Version of Functional Assessment of Multiple Sclerosis: A Quality of Life InstrumentMultiple Sclerosis International · 2011
  46. Potential Impact of B Cells on T Cell Function in Multiple SclerosisMultiple Sclerosis International · 2011
  47. Imaging the Visual Pathway in Neuromyelitis OpticaMultiple Sclerosis International · 2011
  48. Restless Legs Syndrome Presenting as an Acute Exacerbation of Multiple SclerosisMultiple Sclerosis International · 2011
  49. Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple SclerosisMultiple Sclerosis International · 2011
  50. Corpus Callosum Microstructural Changes Correlate with Cognitive Dysfunction in Early Stages of Relapsing-Remitting Multiple Sclerosis: Axial and Radial Diffusivities ApproachMultiple Sclerosis International · 2011